Mark G. Foletta, Director at DEXCOM INC (DXCM), sold 5,305 shares at $81.02 ($430K) on 2025-08-15, disclosed to the SEC on 2025-08-18.
Scheduled sale ($430k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $81.02 | 2,555 | $207K | 48.2% |
| 2 | $81.02 | 2,555 | $207K | 48.2% |
| 3 | $81.54 | 195 | $16K | 3.7% |
| Total | $81.04 avg | 5,305 | $430K | 100% |
| Filing → |
| AMN | SELL | 2026-06-17 | $114K | — | Filing → |
| DXCM | SELL | 2025-07-17 | $468K | — | Filing → |
| DXCM | SELL | 2025-06-18 | $457K | — | Filing → |